FDA Issues Update on CBD:
Still Working, Still Waiting
By Aaron G. Biros, Editor-in-Chief
The FDA published a statement on their progress regarding a path to a regulated CBD marketplace. They also issued an update to Congress about enforcement actions, education, regulatory policy and a timeframe. Most notably, the report provides some insight to their regulatory approach, including mention of treating CBD products like a dietary supplement.